| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 5.66e-06 | 2 | 48 | 2 | GO:0072518 | |
| GeneOntologyBiologicalProcess | negative regulation of bicellular tight junction assembly | 3.86e-07 | 7 | 47 | 3 | GO:1903347 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 3.29e-06 | 45 | 47 | 4 | GO:0030866 | |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 8.55e-06 | 57 | 47 | 4 | GO:0030865 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 1.23e-05 | 20 | 47 | 3 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 1.23e-05 | 20 | 47 | 3 | GO:1903140 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 1.64e-05 | 239 | 47 | 6 | GO:0031032 | |
| GeneOntologyBiologicalProcess | regulation of establishment of cell polarity | 2.46e-05 | 25 | 47 | 3 | GO:2000114 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin-activated signaling pathway | 3.04e-05 | 4 | 47 | 2 | GO:0110061 | |
| GeneOntologyBiologicalProcess | regulation of bicellular tight junction assembly | 3.49e-05 | 28 | 47 | 3 | GO:2000810 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphatase activity | 4.31e-05 | 30 | 47 | 3 | GO:0010923 | |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 4.31e-05 | 30 | 47 | 3 | GO:0032878 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 6.47e-05 | 95 | 47 | 4 | GO:0000281 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 7.08e-05 | 803 | 47 | 9 | GO:0030036 | |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 1.03e-04 | 107 | 47 | 4 | GO:0051492 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 1.11e-04 | 41 | 47 | 3 | GO:1901889 | |
| GeneOntologyBiologicalProcess | negative regulation of dephosphorylation | 1.38e-04 | 44 | 47 | 3 | GO:0035305 | |
| GeneOntologyBiologicalProcess | actin filament organization | 1.43e-04 | 509 | 47 | 7 | GO:0007015 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 1.71e-04 | 122 | 47 | 4 | GO:0110020 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 1.76e-04 | 123 | 47 | 4 | GO:0032231 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 1.86e-04 | 912 | 47 | 9 | GO:0030029 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 1.99e-04 | 127 | 47 | 4 | GO:0061640 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 1.99e-04 | 127 | 47 | 4 | GO:0030038 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 1.99e-04 | 127 | 47 | 4 | GO:0043149 | |
| GeneOntologyBiologicalProcess | cell cycle process | ROCK2 SFPQ WRN ROCK1 CEP152 NUF2 TEX12 TRRAP ANKFN1 CIT IQGAP3 | 3.12e-04 | 1441 | 47 | 11 | GO:0022402 |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 3.13e-04 | 58 | 47 | 3 | GO:0061028 | |
| GeneOntologyBiologicalProcess | positive regulation of connective tissue replacement | 3.90e-04 | 13 | 47 | 2 | GO:1905205 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 4.58e-04 | 158 | 47 | 4 | GO:0045446 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 4.80e-04 | 67 | 47 | 3 | GO:0045601 | |
| GeneOntologyBiologicalProcess | microtubule-based process | 5.55e-04 | 1058 | 47 | 9 | GO:0007017 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 5.86e-04 | 300 | 47 | 5 | GO:0110053 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 6.42e-04 | 74 | 47 | 3 | GO:0010921 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | 6.76e-04 | 864 | 47 | 8 | GO:0051129 | |
| GeneOntologyBiologicalProcess | regulation of connective tissue replacement | 7.60e-04 | 18 | 47 | 2 | GO:1905203 | |
| GeneOntologyBiologicalProcess | endothelium development | 7.78e-04 | 182 | 47 | 4 | GO:0003158 | |
| GeneOntologyBiologicalProcess | endothelial cell development | 8.06e-04 | 80 | 47 | 3 | GO:0001885 | |
| GeneOntologyBiologicalProcess | bicellular tight junction assembly | 8.35e-04 | 81 | 47 | 3 | GO:0070830 | |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 9.31e-04 | 191 | 47 | 4 | GO:0051017 | |
| GeneOntologyBiologicalProcess | actin filament bundle organization | 1.01e-03 | 195 | 47 | 4 | GO:0061572 | |
| GeneOntologyBiologicalProcess | tight junction assembly | 1.06e-03 | 88 | 47 | 3 | GO:0120192 | |
| GeneOntologyBiologicalProcess | apical junction assembly | 1.13e-03 | 90 | 47 | 3 | GO:0043297 | |
| GeneOntologyBiologicalProcess | cytokinesis | 1.19e-03 | 204 | 47 | 4 | GO:0000910 | |
| GeneOntologyBiologicalProcess | tight junction organization | 1.29e-03 | 94 | 47 | 3 | GO:0120193 | |
| GeneOntologyBiologicalProcess | angiotensin-activated signaling pathway | 1.36e-03 | 24 | 47 | 2 | GO:0038166 | |
| GeneOntologyBiologicalProcess | positive regulation of tissue remodeling | 1.36e-03 | 24 | 47 | 2 | GO:0034105 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 1.49e-03 | 217 | 47 | 4 | GO:0030856 | |
| GeneOntologyBiologicalProcess | response to vitamin | 1.54e-03 | 100 | 47 | 3 | GO:0033273 | |
| GeneOntologyBiologicalProcess | connective tissue replacement | 1.60e-03 | 26 | 47 | 2 | GO:0097709 | |
| Domain | Rho_Binding | 6.47e-06 | 2 | 48 | 2 | PF08912 | |
| Domain | Rho-bd_dom | 6.47e-06 | 2 | 48 | 2 | IPR015008 | |
| Domain | ROCK1/ROCK2 | 6.47e-06 | 2 | 48 | 2 | IPR020684 | |
| Domain | DUF4195 | 3.87e-05 | 4 | 48 | 2 | IPR025243 | |
| Domain | DUF4195 | 3.87e-05 | 4 | 48 | 2 | PF13836 | |
| Domain | Pkinase_C | 1.16e-04 | 37 | 48 | 3 | IPR017892 | |
| Domain | Pkinase_C | 1.70e-04 | 42 | 48 | 3 | PF00433 | |
| Domain | HR1 | 1.79e-04 | 8 | 48 | 2 | PF02185 | |
| Domain | AGC-kinase_C | 4.01e-04 | 56 | 48 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.01e-04 | 56 | 48 | 3 | PS51285 | |
| Domain | S_TK_X | 4.01e-04 | 56 | 48 | 3 | SM00133 | |
| Domain | - | 4.26e-04 | 248 | 48 | 5 | 1.25.40.20 | |
| Domain | ANK | 4.50e-04 | 251 | 48 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 4.67e-04 | 253 | 48 | 5 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 4.75e-04 | 254 | 48 | 5 | IPR020683 | |
| Domain | ANK_REP_REGION | 4.75e-04 | 254 | 48 | 5 | PS50297 | |
| Domain | Ankyrin_rpt | 5.47e-04 | 262 | 48 | 5 | IPR002110 | |
| Domain | ZF_DAG_PE_1 | 5.95e-04 | 64 | 48 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.95e-04 | 64 | 48 | 3 | PS50081 | |
| Domain | C1 | 6.22e-04 | 65 | 48 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 6.51e-04 | 66 | 48 | 3 | IPR002219 | |
| Domain | tRNA-bd_arm | 1.72e-03 | 24 | 48 | 2 | IPR010978 | |
| Domain | Ank_2 | 2.24e-03 | 215 | 48 | 4 | PF12796 | |
| Domain | Ank | 2.76e-03 | 228 | 48 | 4 | PF00023 | |
| Domain | C1_1 | 9.43e-03 | 57 | 48 | 2 | PF00130 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.91e-05 | 70 | 36 | 4 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.63e-05 | 74 | 36 | 4 | M41807 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 6.31e-05 | 5 | 36 | 2 | M49031 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 6.31e-05 | 5 | 36 | 2 | MM15221 | |
| Pathway | WP_G13_SIGNALING | 1.21e-04 | 38 | 36 | 3 | M39606 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 1.31e-04 | 39 | 36 | 3 | MM15898 | |
| Pathway | PID_RHOA_PATHWAY | 2.02e-04 | 45 | 36 | 3 | M12 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY | 2.26e-04 | 9 | 36 | 2 | M47546 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 3.44e-04 | 11 | 36 | 2 | MM15046 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 3.44e-04 | 11 | 36 | 2 | M47721 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY | 4.86e-04 | 13 | 36 | 2 | M47547 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 4.86e-04 | 13 | 36 | 2 | M47731 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 5.43e-04 | 149 | 36 | 4 | M41805 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 6.52e-04 | 15 | 36 | 2 | M138 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 6.52e-04 | 15 | 36 | 2 | MM15037 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 7.14e-04 | 69 | 36 | 3 | MM15596 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 7.44e-04 | 16 | 36 | 2 | M40060 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 7.44e-04 | 70 | 36 | 3 | MM15597 | |
| Pathway | WP_LEPTIN_SIGNALING | 9.46e-04 | 76 | 36 | 3 | M39491 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.06e-03 | 19 | 36 | 2 | M27493 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.17e-03 | 20 | 36 | 2 | M18415 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.29e-03 | 323 | 36 | 5 | M27080 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.29e-03 | 21 | 36 | 2 | M47767 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.55e-03 | 23 | 36 | 2 | M41817 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.69e-03 | 24 | 36 | 2 | M2243 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.83e-03 | 25 | 36 | 2 | MM15608 | |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 29162624 | ||
| Pubmed | 1.46e-07 | 8 | 49 | 3 | 25816133 | ||
| Pubmed | Investigation of the esophageal Rho-kinase expression in patients with Barrett's esophagus. | 1.94e-06 | 2 | 49 | 2 | 23789633 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28225294 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 35523828 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15044207 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 29115372 | ||
| Pubmed | ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. | 1.94e-06 | 2 | 49 | 2 | 18414683 | |
| Pubmed | ROCK2 inhibition enhances the thermogenic program in white and brown fat tissue in mice. | 1.94e-06 | 2 | 49 | 2 | 31914704 | |
| Pubmed | Investigation of the Rho-kinase Gene Polymorphism in Primary Open-angle Glaucoma. | 1.94e-06 | 2 | 49 | 2 | 24617500 | |
| Pubmed | Differential regulation of adhesion complex turnover by ROCK1 and ROCK2. | 1.94e-06 | 2 | 49 | 2 | 22348083 | |
| Pubmed | [Ouabain induces Rho-dependent rock activation and membrane blebbing incultured endothelial cells]. | 1.94e-06 | 2 | 49 | 2 | 25916120 | |
| Pubmed | Sulfide induces apoptosis and Rho kinase-dependent cell blebbing in Jurkat cells. | 1.94e-06 | 2 | 49 | 2 | 23479079 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 30771534 | ||
| Pubmed | Rho-associated kinase is a therapeutic target in neuroblastoma. | 1.94e-06 | 2 | 49 | 2 | 28739902 | |
| Pubmed | Matrix rigidity differentially regulates invadopodia activity through ROCK1 and ROCK2. | 1.94e-06 | 2 | 49 | 2 | 26826790 | |
| Pubmed | Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. | 1.94e-06 | 2 | 49 | 2 | 19590140 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24429217 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12778124 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24562870 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18495812 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25934709 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26468018 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 29246448 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28035042 | ||
| Pubmed | ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice. | 1.94e-06 | 2 | 49 | 2 | 26276827 | |
| Pubmed | ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. | 1.94e-06 | 2 | 49 | 2 | 22462535 | |
| Pubmed | Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. | 1.94e-06 | 2 | 49 | 2 | 28679962 | |
| Pubmed | Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction. | 1.94e-06 | 2 | 49 | 2 | 30165352 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 32877952 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 30196430 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 29800294 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 27791202 | ||
| Pubmed | ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease. | 1.94e-06 | 2 | 49 | 2 | 38199985 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18668558 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17167780 | ||
| Pubmed | ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders. | 1.94e-06 | 2 | 49 | 2 | 27033194 | |
| Pubmed | Role of Rho-kinase in regulation of insulin action and glucose homeostasis. | 1.94e-06 | 2 | 49 | 2 | 16098829 | |
| Pubmed | Association of Rho-kinase Gene Polymorphisms with Respiratory Distress Syndrome in Preterm Neonates. | 1.94e-06 | 2 | 49 | 2 | 27269648 | |
| Pubmed | Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma. | 1.94e-06 | 2 | 49 | 2 | 25755711 | |
| Pubmed | Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase. | 1.94e-06 | 2 | 49 | 2 | 24289040 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28709411 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 32234882 | ||
| Pubmed | Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma. | 1.94e-06 | 2 | 49 | 2 | 33278350 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15096457 | ||
| Pubmed | Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. | 1.94e-06 | 2 | 49 | 2 | 23392171 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23250919 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28923399 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17347801 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21471517 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24168723 | ||
| Pubmed | Distinct distribution and localization of Rho-kinase in mouse epithelial, muscle and neural tissues. | 1.94e-06 | 2 | 49 | 2 | 22986902 | |
| Pubmed | Dissecting the roles of ROCK isoforms in stress-induced cell detachment. | 1.94e-06 | 2 | 49 | 2 | 23598717 | |
| Pubmed | Rho kinase inhibitors block melanoma cell migration and inhibit metastasis. | 1.94e-06 | 2 | 49 | 2 | 25840982 | |
| Pubmed | Activation of Rho kinase isoforms in lung endothelial cells during inflammation. | 1.94e-06 | 2 | 49 | 2 | 19201893 | |
| Pubmed | ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression. | 1.94e-06 | 2 | 49 | 2 | 22934846 | |
| Pubmed | ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. | 1.94e-06 | 2 | 49 | 2 | 16098146 | |
| Pubmed | ROCK regulates the intermittent mode of interstitial T cell migration in inflamed lungs. | 1.94e-06 | 2 | 49 | 2 | 29044117 | |
| Pubmed | Functional role of Rho-kinase in ameloblast differentiation. | 1.94e-06 | 2 | 49 | 2 | 21792909 | |
| Pubmed | Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. | 1.94e-06 | 2 | 49 | 2 | 20803696 | |
| Pubmed | Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis. | 1.94e-06 | 2 | 49 | 2 | 26481340 | |
| Pubmed | Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation. | 1.94e-06 | 2 | 49 | 2 | 19997641 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18331468 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 29211497 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 30369081 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 29987023 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8772201 | ||
| Pubmed | Role of Rho kinase isoforms in murine allergic airway responses. | 1.94e-06 | 2 | 49 | 2 | 21565918 | |
| Pubmed | ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. | 1.94e-06 | 2 | 49 | 2 | 19131646 | |
| Pubmed | Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors. | 1.94e-06 | 2 | 49 | 2 | 31302146 | |
| Pubmed | Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. | 1.94e-06 | 2 | 49 | 2 | 23328676 | |
| Pubmed | The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. | 1.94e-06 | 2 | 49 | 2 | 18695890 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 27203208 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20169147 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22355071 | ||
| Pubmed | The ROCK isoforms differentially regulate the morphological characteristics of carcinoma cells. | 1.94e-06 | 2 | 49 | 2 | 28650698 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22942252 | ||
| Pubmed | Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. | 1.94e-06 | 2 | 49 | 2 | 17681946 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23946538 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24170433 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12508221 | ||
| Pubmed | The Rho kinase pathway regulates mouse adult neural precursor cell migration. | 1.94e-06 | 2 | 49 | 2 | 21732490 | |
| Pubmed | Rho kinases play an obligatory role in vertebrate embryonic organogenesis. | 1.94e-06 | 2 | 49 | 2 | 11532918 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 27251065 | ||
| Pubmed | Role of ROCK2 in CD4+ cells in allergic airways responses in mice. | 1.94e-06 | 2 | 49 | 2 | 27886408 | |
| Pubmed | ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells. | 1.94e-06 | 2 | 49 | 2 | 30884801 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18695640 | ||
| Pubmed | Comparative Study of ROCK1 and ROCK2 in Hippocampal Spine Formation and Synaptic Function. | 1.94e-06 | 2 | 49 | 2 | 30826947 | |
| Pubmed | Rho-associated kinases play a role in endocardial cell differentiation and migration. | 1.94e-06 | 2 | 49 | 2 | 15464581 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22205227 | ||
| Pubmed | Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis. | 4.56e-06 | 23 | 49 | 3 | 11086988 | |
| Pubmed | Caffeine inhibits migration in glioma cells through the ROCK-FAK pathway. | 5.83e-06 | 3 | 49 | 2 | 25011614 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25940707 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27513300 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18922892 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19106222 | ||
| Pubmed | Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. | 5.83e-06 | 3 | 49 | 2 | 10209029 | |
| Pubmed | Role of ROCK/NF‑κB/AQP8 signaling in ethanol‑induced intestinal epithelial barrier dysfunction. | 5.83e-06 | 3 | 49 | 2 | 32705263 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23327740 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 31262973 | ||
| Interaction | KRT38 interactions | 3.23e-06 | 172 | 48 | 6 | int:KRT38 | |
| Interaction | NDC80 interactions | 8.51e-06 | 312 | 48 | 7 | int:NDC80 | |
| Interaction | HTRA3 interactions | 1.01e-05 | 18 | 48 | 3 | int:HTRA3 | |
| Interaction | RBM12B interactions | 2.19e-05 | 69 | 48 | 4 | int:RBM12B | |
| Cytoband | 1p22.1 | 5.42e-04 | 32 | 49 | 2 | 1p22.1 | |
| Cytoband | 15q21.3 | 6.49e-04 | 35 | 49 | 2 | 15q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 9.11e-04 | 177 | 49 | 3 | chr15q21 | |
| Cytoband | 19q13.32 | 2.87e-03 | 74 | 49 | 2 | 19q13.32 | |
| GeneFamily | Ankyrin repeat domain containing | 4.47e-05 | 242 | 30 | 5 | 403 | |
| GeneFamily | Proteases, serine | 4.88e-03 | 63 | 30 | 2 | 738 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.05e-05 | 155 | 49 | 5 | M39041 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.57e-08 | 196 | 49 | 6 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.56e-06 | 179 | 49 | 5 | 6718cadcc2d3b64717ed84244ef1242d392662dc | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.83e-06 | 185 | 49 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-06 | 185 | 49 | 5 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.20e-06 | 192 | 49 | 5 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.20e-06 | 192 | 49 | 5 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.26e-06 | 193 | 49 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.37e-06 | 195 | 49 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.37e-06 | 195 | 49 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.43e-06 | 196 | 49 | 5 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.56e-06 | 198 | 49 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.56e-06 | 198 | 49 | 5 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 2.62e-06 | 199 | 49 | 5 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 2.62e-06 | 199 | 49 | 5 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.62e-06 | 199 | 49 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 2.62e-06 | 199 | 49 | 5 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-06 | 199 | 49 | 5 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.62e-06 | 199 | 49 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 129 | 49 | 4 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 130 | 49 | 4 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 132 | 49 | 4 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.61e-05 | 138 | 49 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 142 | 49 | 4 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-05 | 164 | 49 | 4 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-05 | 164 | 49 | 4 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.49e-05 | 168 | 49 | 4 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.65e-05 | 170 | 49 | 4 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.73e-05 | 171 | 49 | 4 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-05 | 174 | 49 | 4 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-05 | 174 | 49 | 4 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.00e-05 | 174 | 49 | 4 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 4.27e-05 | 177 | 49 | 4 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-05 | 179 | 49 | 4 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.56e-05 | 180 | 49 | 4 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.66e-05 | 181 | 49 | 4 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.66e-05 | 181 | 49 | 4 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.66e-05 | 181 | 49 | 4 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.66e-05 | 181 | 49 | 4 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.66e-05 | 181 | 49 | 4 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.76e-05 | 182 | 49 | 4 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-05 | 184 | 49 | 4 | a0831e850bc0b585296ed350fdd075c1f730308e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-05 | 185 | 49 | 4 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 49 | 4 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 49 | 4 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.51e-05 | 189 | 49 | 4 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-05 | 189 | 49 | 4 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 189 | 49 | 4 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 189 | 49 | 4 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.63e-05 | 190 | 49 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.74e-05 | 191 | 49 | 4 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.86e-05 | 192 | 49 | 4 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 5.86e-05 | 192 | 49 | 4 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | CF-Epithelial-Epithelial_cell|CF / Disease state, Lineage and Cell class | 5.98e-05 | 193 | 49 | 4 | 4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820 | |
| ToppCell | CF-Epithelial|CF / Disease state, Lineage and Cell class | 5.98e-05 | 193 | 49 | 4 | 518901c2e36a79c6189cd0d9e6d36dbd4f56a79c | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 49 | 4 | 2cac1b9c4da01faaec9a67ec06f47a7060760225 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 49 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.10e-05 | 194 | 49 | 4 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 195 | 49 | 4 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-05 | 196 | 49 | 4 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-05 | 196 | 49 | 4 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.35e-05 | 196 | 49 | 4 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.35e-05 | 196 | 49 | 4 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.47e-05 | 197 | 49 | 4 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.47e-05 | 197 | 49 | 4 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.47e-05 | 197 | 49 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 6.60e-05 | 198 | 49 | 4 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.73e-05 | 199 | 49 | 4 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 6.73e-05 | 199 | 49 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.73e-05 | 199 | 49 | 4 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.73e-05 | 199 | 49 | 4 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.73e-05 | 199 | 49 | 4 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.86e-05 | 200 | 49 | 4 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.86e-05 | 200 | 49 | 4 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.86e-05 | 200 | 49 | 4 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 6.86e-05 | 200 | 49 | 4 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 6.86e-05 | 200 | 49 | 4 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.86e-05 | 200 | 49 | 4 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 6.86e-05 | 200 | 49 | 4 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.86e-05 | 200 | 49 | 4 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Intermediate|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.35e-04 | 109 | 49 | 3 | 48f675d36fece070410eb9cfe64805f4629e290f | |
| ToppCell | mild_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 2.89e-04 | 117 | 49 | 3 | 85210be67ddc31903764b7fa6d7029d9656753d3 | |
| ToppCell | Club_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.12e-04 | 120 | 49 | 3 | 7f85208f0455f3e634f8e7e81beea60b4ef1d2a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 123 | 49 | 3 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 130 | 49 | 3 | 3041d20fe964d282d95c0312396f26bc93929056 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 130 | 49 | 3 | 8c81853c806e9a0d562e00dc5e00a8fc569a854c | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 130 | 49 | 3 | 3b6a8eaef593db73c2fad2260b9f1e15950ccb70 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-04 | 134 | 49 | 3 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.31e-04 | 134 | 49 | 3 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 141 | 49 | 3 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 141 | 49 | 3 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 5.75e-04 | 148 | 49 | 3 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | MS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster | 5.87e-04 | 149 | 49 | 3 | 08fb6be5599c5988890c851ce5ac6781c319948e | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.10e-04 | 151 | 49 | 3 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.33e-04 | 153 | 49 | 3 | fc0d2d50aa3b6b2772bbf3626c9df5c5e8d7d11e | |
| ToppCell | PND01-03-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.33e-04 | 153 | 49 | 3 | 2482247d9c39c7b99bb45fb9153442f64fd6012f | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-04 | 154 | 49 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-04 | 154 | 49 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.58e-04 | 155 | 49 | 3 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| Drug | hexamethylmelamine | 2.40e-06 | 102 | 48 | 5 | CID000002123 | |
| Drug | Rockout | 4.35e-06 | 2 | 48 | 2 | CID000644354 | |
| Drug | 3,3-dimethylacryloyl chloride | 4.35e-06 | 2 | 48 | 2 | CID000102394 | |
| Drug | RS 102221 | 7.02e-06 | 18 | 48 | 3 | CID003693566 | |
| Drug | diguanosine pentaphosphate | 2.60e-05 | 4 | 48 | 2 | CID004577574 | |
| Drug | tetrahydrooxazine | 4.33e-05 | 5 | 48 | 2 | CID000449101 | |
| Drug | brazilein | 6.49e-05 | 6 | 48 | 2 | CID006453902 | |
| Drug | levormeloxifene | 6.49e-05 | 6 | 48 | 2 | ctd:C108255 | |
| Drug | thymol blue | 6.49e-05 | 6 | 48 | 2 | CID000065565 | |
| Drug | AC1L1CTF | 6.49e-05 | 6 | 48 | 2 | CID000002056 | |
| Drug | 6-BME | 9.08e-05 | 7 | 48 | 2 | CID005748218 | |
| Drug | AC1L2VEC | 9.08e-05 | 7 | 48 | 2 | CID000129320 | |
| Drug | GGTI-297 | 1.21e-04 | 8 | 48 | 2 | CID009956145 | |
| Drug | heptenoic acid | 1.21e-04 | 8 | 48 | 2 | CID000029373 | |
| Drug | N-palmitoyl-serine | 1.21e-04 | 8 | 48 | 2 | CID000085997 | |
| Drug | oxethazaine | 1.21e-04 | 8 | 48 | 2 | CID000004621 | |
| Drug | SC-46275 | 1.21e-04 | 8 | 48 | 2 | CID005311427 | |
| Drug | Y-26763 | 1.21e-04 | 8 | 48 | 2 | CID000121878 | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 1.02e-04 | 10 | 45 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | Primary microcephaly | 5.15e-04 | 22 | 45 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 5.15e-04 | 22 | 45 | 2 | C3711387 | |
| Disease | Ovarian Serous Adenocarcinoma | 5.64e-04 | 23 | 45 | 2 | C1335177 | |
| Disease | Abnormality of radial ray | 1.17e-03 | 33 | 45 | 2 | C4228778 | |
| Disease | serum selenium measurement | 2.98e-03 | 53 | 45 | 2 | EFO_0005266 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLKILKNNIRFMNHM | 326 | Q6N043 | |
| LHKEMAQRMEQANKK | 286 | Q7Z3E2 | |
| AQKAHAMSANMNKAL | 456 | O94986 | |
| HKTMLQMILCNKSYQ | 191 | Q9UJ72 | |
| DDKMEHAQKLMRLQN | 61 | Q9BXU8 | |
| LNDLEKKHAMLEMNA | 1121 | O14578 | |
| KKHAMLEMNARSLQQ | 1126 | O14578 | |
| RDSHLKMLAKQEAQM | 191 | Q96NW4 | |
| QDLLKMNINMNKHLV | 101 | Q9H867 | |
| KMNALHMLDIKEHNG | 466 | Q9BYH8 | |
| MNLLRNNSCLSKMKN | 456 | O14920 | |
| MKCHQQQLQRMKENA | 181 | Q9UHH9 | |
| CKMMLSVNNFVSHQK | 36 | Q86VF7 | |
| AVAAMAKDKANMQHR | 341 | P55795 | |
| QMMVQENKGHAVSLK | 511 | Q86VH2 | |
| HNFMMDTQLTKRIKN | 556 | Q9UGI6 | |
| KMQQLNAAHQEALMK | 151 | Q9BZD4 | |
| NKDHRNDIMLVKMAS | 136 | Q9UBX7 | |
| MKMLQARKQHMSTQL | 761 | Q96QE4 | |
| MLAQAKMEKAANARN | 251 | Q86VI3 | |
| HLRNKTEKNTQEMMK | 51 | A6NG13 | |
| NKAMHLSQLDMILDQ | 896 | Q5T9S5 | |
| DMNEHLQGQLNSMKK | 1241 | Q0VF96 | |
| AHCKKMQERMSAQLA | 116 | Q8WZ74 | |
| DNLARQMIMKDKNWH | 116 | O14791 | |
| LDQMALQCDMTKKNR | 4371 | Q9NYC9 | |
| NQMEMEHSLILNNLK | 401 | Q5T7M9 | |
| MLKMKLHNGSNNFRL | 146 | P21453 | |
| KGNLKQHMLTHQMRD | 1041 | Q9NSC2 | |
| NFQSLAMKHMDLKQM | 16 | Q8WUF5 | |
| NHQLKEAMKLNNQAM | 51 | Q96CV9 | |
| LRHMKALMNEKAQAA | 51 | Q9ULN7 | |
| NKLKENMERACLMSL | 381 | Q14191 | |
| QQMMDHEARLLVAKA | 696 | Q9UQ90 | |
| KMTQQMQNLHLCQSK | 71 | Q8N957 | |
| ELHNQEMQKRKEMQL | 551 | P23246 | |
| ADKNVPNLHVMKAMQ | 36 | P46783 | |
| KDHRMKLMQQQQEVA | 336 | O15164 | |
| ENARMMERMSLKHQN | 286 | Q5TAP6 | |
| IKAKLHQMLKNNMAS | 131 | Q86T26 | |
| ADKNVPNLHVMKAMQ | 36 | Q9NQ39 | |
| MQQNKKGDMTHELVR | 1511 | Q9HBL0 | |
| KMSEKQLKQENNHLM | 821 | O75116 | |
| MVVKHQKELNDMQAQ | 1051 | Q13464 | |
| CSKVLKNNIRFMNHM | 321 | Q8ND82 | |
| LKKRMQQIMAHCFLA | 466 | Q6ZVT0 | |
| NMLQSGLHKQHMKDL | 791 | Q9Y4A5 | |
| LQKVQLDSSHKQAMM | 366 | Q8NHX9 | |
| MMANHLVKPDNRNCK | 1 | Q9BXU0 | |
| RMCELMKQQETHLKQ | 371 | P40222 |